Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 22.52
+0.36 (1.62%)
Aug 4, 2026, 3:04 PM CST
Lifecome Biochemistry Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 470.43 | 516.58 | 649.37 | 507 | 329.85 | 363.39 |
Revenue Growth | -23.73% | -20.45% | 28.08% | 53.71% | -9.23% | 17.93% |
Gross Profit Gross Profit Growth | 58.6 | 15.89 | -106.69 | -104.74 | -51.51 | 51.84 |
Operating Income Operating Income Growth | -26.84 | -83.5 | -210.75 | -192 | -116.7 | -13.96 |
Net Income Net Income Growth | -73.38 | -139.26 | -444.86 | -221.82 | -121.94 | -26.04 |
Earnings Per Share EPS Growth | -0.47 | -0.90 | -2.86 | -1.44 | -0.79 | -0.17 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Animal Health Series Animal Health Series Growth | 424.07 | 379.3 | 358.2 | 279.56 | 228.31 | 246.89 |
Plant Protection Series Plant Protection Series Growth | 16.92 | 25.41 | 28.56 | 31.93 | 29.41 | 50.85 |
Photovoltaic Film Photovoltaic Film Growth | - | 83.92 | 231.3 | 143.77 | - | - |
Others Others Growth | 22.23 | 27.95 | 31.31 | 16.15 | 18.35 | 21.04 |
Total Total Growth | 470.43 | 516.58 | 649.37 | 507 | 329.85 | 363.39 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 51.4 | 55.6 | 24.8 | 84.38 | 23.76 | 97.5 |
Total Debt Total Debt Growth | 469.22 | 507.55 | 949.6 | 1,087 | 395.6 | 321.19 |
Net Cash (Debt) Net Cash Growth | -417.82 | -451.94 | -924.8 | -1,002 | -371.84 | -223.7 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.70 | -2.92 | -5.95 | -6.51 | -2.41 | -1.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -55.29 | -25.08 | 141.41 | -186.76 | -8.83 | 35.17 |
Capital Expenditures CapEx Growth | -123.34 | -129.8 | -125.06 | -464.54 | -137.32 | -357.17 |
Free Cash Flow Free Cash Flow Growth | -178.63 | -154.88 | 16.35 | -651.3 | -146.15 | -322 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 12.46% | 3.08% | -16.43% | -20.66% | -15.62% | 14.27% |
Operating Margin | -5.71% | -16.16% | -32.45% | -37.87% | -35.38% | -3.84% |
Pretax Margin | -15.49% | -26.88% | -65.93% | -47.51% | -40.66% | -8.90% |
Profit Margin | -15.60% | -26.96% | -68.51% | -43.75% | -36.97% | -7.17% |
FCF Margin | -37.97% | -29.98% | 2.52% | -128.46% | -44.31% | -88.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | 189.81 | - | - | - |
PS Ratio | 7.44 | 10.14 | 4.78 | 6.43 | 24.69 | 4.66 |